DEVICE CATEGORY · LTI
Implant, Intragastric For Morbid Obesity
FDA classification: Unknown. Device class 3.
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
Allurion Gastric Balloon SystemP250023/S002 | Allurion Technologies, Inc. | PMA supplement | Sep 23, 2026 | FDA |
Allurion Gastric Balloon SystemP250023/S001 | Allurion Technologies, Inc. | PMA supplement | Sep 9, 2026 | FDA |
| Allurion Technologies, Inc. | PMA approval | Feb 20, 2026 | FDA | |
ORBERA INTRAGASTRIC BALLOONP140008/S028 | BOSTON SCIENTIFIC CORPORATION | PMA supplement | Jan 5, 2026 | FDA |
Source information
Follow the FDA links to view the original records.



